-
A Phase Ib/II Study of Regorafenib and Paclitaxel in Beyond First-line Advanced Esophagogastric Carcinoma (REPEAT)
Study
EGAS00001006054
-
Tumor-resident T-cell regulate responses to checkpoint blockade immunotherapies
Study
EGAS50000000826
-
LuCaP cell line ChIP-seq
Dataset
EGAD50000001345
-
SCRNA10X_SA_CHIP0080_001
Dataset
EGAD00001006461
-
SCRNA10X_SA_CHIP0080_002
Dataset
EGAD00001006462
-
SCRNA10X_SA_CHIP0006_001
Dataset
EGAD00001006460
-
SCRNA10X_SA_CHIP0141_004
Dataset
EGAD00001006463
-
SCRNA10X_SA_CHIP0142_001
Dataset
EGAD00001006464
-
SCRNA10X_SA_CHIP0142_003
Dataset
EGAD00001006465
-
SCRNA10X_SA_CHIP0146_002
Dataset
EGAD00001006466